How are you feeling today? Keep up to date on news and stories related to healthcare here!
SWEDESBORO, N.J. — (BUSINESS WIRE) — #BlueRabbit — Wedgewood Equine, a dedicated division of Wedgewood, the nation’s largest provider of compounded veterinary medications, is excited to unveil Blue Rabbit for equine veterinarians at this year’s American Association of Equine Practitioners (AAEP) 70th
OXFORD, England & SPRINGFIELD, N.J. — (BUSINESS WIRE) — Orbit Discovery, a leading provider of peptide discovery services, and Evergreen Theragnostics, a radiopharmaceutical company at the forefront of precision medicine, on Tuesday announced an extension to their research collaboration to find novel
HAYWARD, Calif. — (BUSINESS WIRE) — #Biotech — Eikon Therapeutics, Inc., a pioneering biotechnology company that leverages advanced engineering to enhance drug discovery and development, recently announced that Michael A. Klobuchar has been appointed Chief Operating Officer. He joins Eikon from
RAHWAY, N.J. — (BUSINESS WIRE) — Merck (NYSE: MRK), known as MSD outside of the United States and Canada, recently announced that Dr. Eliav Barr, senior vice president, head of global clinical development and chief medical officer, Merck Research Laboratories, is scheduled
Collaboration to bring Cannabis Infused Artisan Chocolate and Premium Gummies to New Jersey and Maryland Markets NEW YORK — (BUSINESS WIRE) — The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQX: CBSTF) (FSE: 3LP) (“The Cannabist Company” or the “Company”),
DENVER — (BUSINESS WIRE) — #FEEES — EvoEndo®, Inc. (EvoEndo) announces that Joseph M. Sanzari Children’s Hospital is the first provider in New Jersey to bring Sedation-Free Transnasal Endoscopy (TNE) of the Upper Gastrointestinal Tract to patients aged five and older
People over 65 have been among the first in line to receive Covid-19 vaccinations. And they are leading a wave in new travel bookings. — NYT: Top Stories
The agency has not fully reckoned with airborne transmission of the coronavirus in settings like hospitals, schools and meatpacking plants, experts said. — NYT: Top Stories
Partnership aims to accelerate access to breakthrough therapies in order to combat difficult-to-treat and often drug-resistant fungal infections in Greater China SCYNEXIS will receive a $10 million upfront payment and will also be eligible to receive development and commercial milestones, plus low